LSE - Delayed Quote SEK

Medicover AB (publ) (0RPS.L)

153.67 +21.46 (+16.23%)
At close: April 26 at 5:51 PM GMT+1
Key Events
Loading Chart for 0RPS.L
DELL
  • Previous Close 132.21
  • Open 141.00
  • Bid --
  • Ask --
  • Day's Range 141.00 - 160.99
  • 52 Week Range 119.30 - 187.50
  • Volume 5,518
  • Avg. Volume 6,179
  • Market Cap (intraday) 215.809M
  • Beta (5Y Monthly) 1.51
  • PE Ratio (TTM) 2.59
  • EPS (TTM) 0.59
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.

www.medicover.com

45,316

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: 0RPS.L

Performance Overview: 0RPS.L

Trailing total returns as of 4/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0RPS.L
2.15%
MSCI WORLD
5.23%

1-Year Return

0RPS.L
12.79%
MSCI WORLD
19.98%

3-Year Return

0RPS.L
35.57%
MSCI WORLD
12.82%

5-Year Return

0RPS.L
0.00%
MSCI WORLD
53.42%

Compare To: 0RPS.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0RPS.L

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.01%

  • Return on Assets (ttm)

    2.06%

  • Return on Equity (ttm)

    3.55%

  • Revenue (ttm)

    1.75B

  • Net Income Avi to Common (ttm)

    17.6M

  • Diluted EPS (ttm)

    0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    62M

  • Total Debt/Equity (mrq)

    189.99%

  • Levered Free Cash Flow (ttm)

    70.71M

Company Insights: 0RPS.L

People Also Watch